NGVT analyst estimates

Ingevity (NGVT) analyst ratings, the average price target and its range, and every firm's latest call.

NGVT analyst ratings and price targets

DateFirmCallTarget
Mar 2, 2026BMO CapitalIngevity Corp (NGVT) PT Raised to $83 at BMO Capital$83.00
Feb 26, 2026JefferiesIngevity Corp (NGVT) PT Raised to $82 at Jefferies$82.00
Jan 28, 2026Wells FargoIngevity price target raised to $65 from $60 at Wells Fargo$65.00
Dec 10, 2025BMO CapitalIngevity price target raised to $70 from $64 at BMO Capital$70.00
Sep 5, 2025BMO CapitalIngevity price target raised to $68 from $62 at BMO Capital$68.00
Aug 7, 2025BMO CapitalIngevity price target raised to $62 from $56 at BMO Capital$62.00
Oct 31, 2024BMO CapitalIngevity Corp (NGVT) PT Raised to $47 at BMO Capital$47.00
Aug 5, 2024BMO CapitalIngevity price target lowered to $42 from $45 at BMO Capital$42.00
Jul 10, 2024BMO CapitalIngevity price target lowered to $45 from $48 at BMO Capital$45.00
May 7, 2024Loop Capital MarketsIngevity Corp (NGVT) PT Raised to $56 at Loop Capital$56.00
Apr 22, 2024JefferiesJefferies Upgrades Ingevity Corp (NGVT) to Buy, 'Activated Carbon Solid, Intermediate Chemicals Rebound Likely'$62.00
Feb 2, 2023Loop Capital MarketsLoop Capital Upgrades Ingevity Corp (NGVT) to Buy$100.00

Updated 2026-11-03 11:30 UTC